NCT03340012

Brief Summary

The treatment of intrabony defects in patients with aggressive periodontitis remains a challenging procedure and novel therapeutic strategies are sought. The purpose of this study is to compare the clinical and radiographic outcomes of using guided tissue regeneration (GTR) with radiation-sterilized allogenic bone grafts (material prepared in the Central Tissue Bank in Warsaw, Poland) versus guided tissue regeneration with xenogenic grafts (Bio-Oss®, Geistlich Biomaterials, Princeton, New Jersey, United States) in the treatment of localized intrabony defects in patients with aggressive periodontitis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2018

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 8, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 13, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

January 5, 2018

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 5, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 5, 2019

Completed
Last Updated

November 13, 2017

Status Verified

November 1, 2017

Enrollment Period

1.3 years

First QC Date

November 8, 2017

Last Update Submit

November 9, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Clinical attachment level (CAL)

    CAL will be measured in millimeters on the study teeth at 6 locations as a distance from the cementoenamel junction to the bottom of the gingival sulcus. The average differences between 12 months and baseline measurements at the sites with the most advanced attachment loss at baseline will be compared.

    Baseline and 12 months after surgery

Study Arms (2)

GTR + radiation-sterilize allogenic bone graft (TEST)

EXPERIMENTAL

The surgical procedure will be performed in line with minimally invasive surgical technique by Cortellini and Tonetti (2007). The intrabony defects will be debrided and the roots will be planned. The required quantity of radiation-sterilized allogenic bone graft will be delivered into intrabony defects. Subsequently, a trimmed collagen membrane will be placed over graft. The flaps will be sutured with non-absorbable modified internal mattress sutures.

Device: GTR + radiation-sterilize allogenic bone graft

GTR + xenogenic graft (CONTROL)

ACTIVE COMPARATOR

The surgical procedure will be performed in line with minimally invasive surgical technique by Cortellini and Tonetti (2007). The intrabony defects will be debrided and the roots will be planned. The required quantity of xenogenic graft will be delivered into intrabony defects. Subsequently, a trimmed collagen membrane will be placed over graft. The flaps will be sutured with non-absorbable modified internal mattress sutures.

Device: GTR + xenogenic graft

Interventions

Guided tissue regeneration of intrabony defects with collagen membrane (Bio-Gide® Perio, Geistlich Biomaterials) and radiation-sterilized allogenic bone graft from the Central Tissue Bank in Warsaw

GTR + radiation-sterilize allogenic bone graft (TEST)

Guided tissue regeneration of intrabony defects with collagen membrane (Bio-Gide® Perio, Geistlich Biomaterials) and xenogenic graft (Bio-Oss®, Geistlich Biomaterials)

GTR + xenogenic graft (CONTROL)

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Diagnosis of aggressive periodontitis in line with American Academy of Periodontology classification (Lang et al. 1999)
  • Familial aggregation (history of periodontitis in parents or siblings)
  • Presence of at least two teeth with probing pocket depth (PPD) ≥ 6mm and clinical attachment level (CAL) ≥ 5 mm associated with an intrabony defect of at least 3 mm as detected in diagnostic periapical radiographs
  • No furcation involvement of the teeth presenting the intraosseous defects
  • The width of keratinized tissue on the facial aspect of the selected teeth ≥ 2 mm

You may not qualify if:

  • Full-mouth plaque index ≥ 20% (Ainamo \& Bay 1975)
  • Full-mouth sulcus bleeding index ≥ 15% (Mühlemann \& Son 1971)
  • Smoking more than 10 cigarettes/day
  • Systemic diseases with compromised healing potential of infectious diseases
  • Drugs affecting periodontal health / healing
  • Pregnant and lactating females
  • Previous periodontal surgery in the area

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Periodontology and Oral Mucosa Diseases, Medical University of Warsaw

Warsaw, Mazowsze, 00-246, Poland

Location

MeSH Terms

Conditions

Aggressive Periodontitis

Condition Hierarchy (Ancestors)

PeriodontitisPeriodontal DiseasesMouth DiseasesStomatognathic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 8, 2017

First Posted

November 13, 2017

Study Start

January 5, 2018

Primary Completion

May 5, 2019

Study Completion

May 5, 2019

Last Updated

November 13, 2017

Record last verified: 2017-11

Locations